Fly News Breaks for April 21, 2015
GILD, VRTX
Apr 21, 2015 | 13:34 EDT
After Bernstein suggested in a note to investors earlier that Gilead (GILD) should buy Vertex (VRTX), Maxim responded in its own note that it does not believe paying a premium to buy Vertex makes sense before the company has data showing efficacy for Kalydeco in heterozygotes. Maxim keeps a Hold rating and $121 price target on Vertex shares.
News For VRTX;GILD From the Last 2 Days
There are no results for your query VRTX;GILD